Genext Genomics Private Limited - Due diligence report

A 360° intelligence report on Genext Genomics: trust score, financial health, credit view, compliance, directors, growth and distress signal…

2011-01-24 Nagpur, Maharashtra Active Unlisted Active Compliant
Share
Connect MCP
GG Genext Genomics Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Genext Genomics — 360° Intelligence Report

Generated from MCA filings & public records
75/100
Trust Score
Low Risk

Genext Genomics is assessed as Low Risk with a Trust Score of 75/100. Genext Genomics is an active private limited indian non-government company incorporated in 2011, operating in the Life Sciences sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 14 Aug 2026 from the latest processed filings. Genext Genomics Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
75/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
25/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
MANJIRI SANDEEP SINGH 01234567 Director 01/04/2018 6 yrs Approved
SUPRIYA KASHIKAR 01234567 Director 01/04/2018 6 yrs Approved
ASHWIN RAVI KASHIKAR 01234567 Director 01/04/2018 6 yrs Approved
SHIVALI VAIBHAV KASHIKAR 01234567 Director 01/04/2018 6 yrs Approved
RAVI MADAN KASHIKAR 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2020 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
3 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: SUPRIYA KASHIKAR (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 70
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Asset base grew 1.42 - capacity expansion.
Operating for 15+ years.
Active GST registration(s).
Distress signals & risk flags
Negative net worth.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence84/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment55/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view58/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 11 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
16 Nov 2019
Securities allotted
29000 Equity Shares Without Differential Rights - 29.00 Lakh raised
16 Feb 2018
Director appointed
SUPRIYA KASHIKAR (Whole-time director)
29 Dec 2012
Securities allotted
1000 Equity Shares Without Differential Rights - 1.00 Lakh raised
30 Apr 2011
Securities allotted
1000 Equity Shares Without Differential Rights - 1.00 Lakh raised
24 Jan 2011
Incorporated
Registered with Roc Nagpur
Director appointed
MANJIRI SANDEEP SINGH (Director)
Director appointed
ASHWIN RAVI KASHIKAR (Director)
Director appointed
SHIVALI VAIBHAV KASHIKAR (Director)
Director appointed
RAVI MADAN KASHIKAR (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2020 annual return.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Longping India Seed R&D Centre Private Limited U74999TG2016FTC109517 Hyderabad, Telangana, India
Anima Pharmaceuticals Private Limited U74999MH2012PTC230494 Mumbai, Maharashtra, India
Glocal Research And Consultancy Services Private Limited U74140TG2000PTC033778 Hyderabad, Telangana, India
Vidhan Healthcare Private Limited U85200RJ2017PTC057534 Bikaner, Rajasthan, India
Intelliscend Nddr Private Limited U24230MH2019PTC323470 Thane, Maharashtra, India
Virtis Bio Labs U85195TZ2015PTC021034 Salem, Tamil Nadu, India
Adarsh Logistics Private Limited U60200DL2009PTC186561 New Delhi, Delhi, India
Indohealth Consultant Private Limited U85300MH2019PTC320942 Aurangabad, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Genext Genomics before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Genext Genomics: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 75/100, margin trends, ownership structure and peer set for Genext Genomics - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 75/100, distress signals and MSME payment-delay disclosures - know whether Genext Genomics pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Genext Genomics - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Genext Genomics an active company?

Genext Genomics has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Genext Genomics financially healthy?

Genext Genomics has a Financial Health Score of 25/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Genext Genomics?

Its overall Trust Score is 75/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Genext Genomics?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 5 active director(s) are on record.

Does Genext Genomics have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Genext Genomics up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Genext Genomics?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.